Levothyroxine sodium
- Product NDC
- 71335-2538
- 11-digit product format
- 713352538
- Labeler code
- 71335
- Product ID
- 71335-2538_f7c72bdd-38c1-4531-87c4-55761f0d6080
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Levothyroxine sodium
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Bryant Ranch Prepack
- Application
- ANDA207588
- Marketing category
- ANDA
- Marketing start
- 2022-09-21
- Substance
- LEVOTHYROXINE SODIUM
- Active strength
- 88 ug/1
- Pharmacologic classes
- Thyroxine [CS], l-Thyroxine [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Levothyroxine sodium
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| LEVOTHYROXINE SODIUM | 88 ug/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | 9J765S329G |
| Rxcui | 966253 |
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|
| 71335-2538-1 | 71335253801 | 30 TABLET in 1 BOTTLE (71335-2538-1) | 30 tablet | 2024-12-10 | No | No | Historical |
| 71335-2538-2 | 71335253802 | 90 TABLET in 1 BOTTLE (71335-2538-2) | 90 tablet | 2024-12-10 | No | No | Historical |
| 71335-2538-3 | 71335253803 | 28 TABLET in 1 BOTTLE (71335-2538-3) | 28 tablet | 2024-12-10 | No | No | Historical |
| 71335-2538-4 | 71335253804 | 100 TABLET in 1 BOTTLE (71335-2538-4) | 100 tablet | 2024-12-10 | No | No | Historical |
| 71335-2538-5 | 71335253805 | 60 TABLET in 1 BOTTLE (71335-2538-5) | 60 tablet | 2024-12-10 | No | No | Historical |